Yan Shi
China Pharmaceutical University(CN)Xiamen University(CN)Nanjing Medical University(CN)University of Science and Technology Beijing(CN)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, melanin and skin pigmentation, Phytochemicals and Antioxidant Activities, Biochemical Analysis and Sensing Techniques, DNA Repair Mechanisms
Most-Cited Works
- → ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models(2007)764 cited
- → Lipase Inhibitors for Obesity: A Review(2020)390 cited
- → Discovery of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the Treatment of Cancer(2008)266 cited
- → Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors(2015)262 cited
- → Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo(2005)244 cited
- → Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor(2011)